24 June 2019
From e-health to digital Health: Telemedicine, Electronic Healthcare File, Artificial Intelligence
www.twobirds.com/en/news/articles/2019/global/from-e-health-to-digital-health-telemedicine-electronic-healthcare-file-artificial-intelligence

In the last five decades we have been assisting on the digitalization of society and consequently of the healthcare sector; we have been using terms such as eHealth, medical informatics, health informatics, ...

24 May 2019
Can CRISPR save the Cavendish?
www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

05 February 2019
"Effective enforcement of EU competition rules in the pharmaceutical law remains a matter of high priority…"
www.twobirds.com/en/news/articles/2019/global/effective-enforcement-of-eu-competition-rules-in-pharmaceutical-law

So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.

08 May 2019
Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

22 November 2019
Access to toxicity study reports and protection of commercial interests
www.twobirds.com/en/news/articles/2019/uk/access-to-toxicity-study-reports-and-protection-of-commercial-interests

Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...

07 February 2019
German Federal Patent Court denies request for preliminary grant of a compulsory license – Where do we go from here?
www.twobirds.com/en/news/articles/2019/germany/german-federal-patent-court-denies-request-for-preliminary-grant-of-compulsory-license

Sanofi sought a compulsory licence for the distribution of its high cholesterol drug Praluent® but this was dismissed in preliminary proceedings (docket no: 3 LiQ 1/18).

02 July 2019
Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)

07 February 2019
New 2019 French Patent/Software box regime: taxation at a reduced rate of 10%
www.twobirds.com/en/news/articles/2019/france/new-french-patent-software-box-regime-tax-at-a-reduced-rate-of-7pc

This new regime, applicable either to types of intangible assets or to a family of products or services, provides taxation at a reduced rate of 10% of net income generated by industrial property including patents and ...

02 December 2019
The French Health Data Hub becomes reality
www.twobirds.com/en/news/articles/2019/france/the-french-health-data-hub-becomes-reality

The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).

15 November 2018
Supreme Court defines plausibility in the context of sufficiency
www.twobirds.com/en/news/articles/2018/uk/supreme-court-defines-plausibility-in-the-context-of-sufficiency

A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.